Incidence of dementia · cognitively healthy people in late life
Aspirin showed no clear difference in incidence of dementia compared with placebo (high certainty).
1 finding from 1 review
Specific adverse events: haemorrhage · cognitively healthy people in late life
Aspirin leads to higher adverse events (haemorrhage) compared with placebo (high certainty).
1 finding from 1 review
All‐cause mortality · cognitively healthy people in late life
Aspirin leads to higher mortality compared with placebo (high certainty).
1 finding from 1 review
Cognitive decline · cognitively healthy people in late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Activities of daily living · cognitively healthy people in late life
Aspirin showed no clear difference in activities of daily living compared with placebo (high certainty).
1 finding from 1 review
Health‐related quality of life · cognitively healthy people in late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · cognitively healthy people in late life
Other NSAIDs showed no clear difference in mortality compared with placebo (moderate certainty).
1 finding from 1 review
Incidence of mild cognitive impairment · cognitively healthy people in late life
Other NSAIDs showed no clear difference in incidence of mild cognitive impairment compared with placebo (low certainty).
1 finding from 1 review
Activities of daily living · cognitively healthy people in late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · cognitively healthy people in late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of dementia · older people with age‐related memory loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Gastrointestinal adverse events · older people with age‐related memory loss
NSAIDs (celecoxib) may leads to higher adverse events – gastrointestinal compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortality · older people with age‐related memory loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive decline · older people with age‐related memory loss
1 finding from 1 review
Activities of daily living · older people with age‐related memory loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · older people with age‐related memory loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Incidence of Alzheimer's disease · people with MCI
The intervention probably leads to higher incidence of Alzheimer's disease (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events – cardiovascular · people with MCI
The intervention showed no clear difference in adverse events – cardiovascular (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events – gastrointestinal · people with MCI
The intervention probably leads to higher adverse events – gastrointestinal (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality · people with MCI
The intervention showed no clear difference in mortality (moderate certainty).
1 finding from 1 review